Brazilian Generic Drug Registration Sets Standard For ‘Pipeline’ Patents 13/05/2010 by Claudia Jurberg for Intellectual Property Watch 5 Comments The first Brazilian generic drug against erectile dysfunction recently received registration at the National Surveillance Agency – a unit of the Health Ministry. The Viagra generic’s registration was only possible because of a decision of the Superior Court that will terminate the drug patent next month, said Odnir Finotti, president of the Pro-Generics Association.
US, WIPO Officials Assess Patent Reform, PCT, Copyright Priorities 10/05/2010 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment NEW YORK – Republican and Democratic lawmakers in the United States are “hotlining” colleagues to ascertain if there is any objection to moving patent reform quickly through the US Senate, a representative of a major stakeholder in the debate said here Friday. Meanwhile, the US Copyright Office is working to get its priorities through a restructured Congress, and a World Intellectual Property Organization official warned of a possible divide in WIPO’s norm-setting activities.
India Overturns Patent On AIDS Patient Drug 05/05/2010 by Intellectual Property Watch 2 Comments The Chennai Patent Office in India last week overturned the patent on Valganciclovir, an expensive drug used to prevent an infection to which people with HIV/AIDS or organ recipients are susceptible, an Indian lawyers’ group said today. The patent office decided that the patent held by Swiss company Roche lacked inventive step and did not […]
Shareholders In 3G Mobile Patent Company Seek US Investigation Of Nokia, Ericsson 23/04/2010 by Dugie Standeford for Intellectual Property Watch Leave a Comment Two shareholders in a Pennsylvania company with patents key to third generation (3G) mobile communications want the US Department of Justice to investigate European mobile phone manufacturers Nokia and Ericsson and others for failing to pay royalties for use of the technology. Antitrust scrutiny is needed to prevent the same thing from happening as the next generation of mobile phones rolls out, Richard Monahan and Kent Greene say.
Obama Administration Tells Senate It Supports Patent Reform Changes 21/04/2010 by Intellectual Property Watch 3 Comments The Obama administration supports changes to the United States patent reform bill, said US Secretary of Commerce Gary Locke in a letter sent late yesterday to members of the Senate Judiciary Committee. The amendments in question would allow the US Patent and Trademark Office to adjust fees to cover the actual costs of patent processing […]
US Govt Economic Report: Patent Reform Will Boost Jobs 21/04/2010 by Intellectual Property Watch Leave a Comment Patent reform in America will spur high-paying job creation and economic growth, claims a new paper by senior economic officials at the US Department of Commerce and the US Patent and Trademark Office. Issued as the US Congress weighs patent legislation, the report found reform could reduce patent pendency by 40 percent. This is important, […]
UNITAID Patent Pool Budget Approved; Implementation To Begin 13/04/2010 by Kaitlin Mara for Intellectual Property Watch 4 Comments Today, board members of international drug purchasing mechanism UNITAID approved a 2010 budget for a pioneering patent pool initiative.
China’s Latest Draft Disposal Rules For Patents In Standards A Step Forward? 01/04/2010 by Intellectual Property Watch 2 Comments On 21 January, 2010, the China National Institute of Standardization (CNIS) issued and requested comments from all stakeholders on its Disposal Rules for Inclusion of Patents in National Standards (Disposal Rules).
Unbiased HIV Patent Pool — A Free-Market, Middle-Income Countries Open Model 01/04/2010 by Intellectual Property Watch 4 Comments Brand name pharmaceutical companies’ concerns about profit losses related to the UNITAID patent pool might undermine access to newer and appropriate HIV medicine formulations in resource-limited settings. A universally agreed strategy to supplement UNITAID plan is therefore needed, writes Daniele Dionisio.
US Court Ruling Casts Gene Patenting Into Doubt 30/03/2010 by Intellectual Property Watch 1 Comment A New York federal court ruled yesterday that patents on genes associated with hereditary breast and ovarian cancer are invalid, in the first time a court decided that patents on genes are unlawful, according to the American Civil Liberties Union (ACLU).